Ticker
HEMO
Analysis
Hemogenyx Pharmaceuticals Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to HEMO.
Hemogenyx Pharmaceuticals Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to HEMO.
HEMO
Stock
$71.6M
Health Technology
Biotechnology
GBX
Hemogenyx Pharmaceuticals Plc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Hemogenyx Pharmaceuticals PLC Announces Notice of
Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant
Hemogenyx Pharmaceuticals plc has successfully raised £3,000,000 through a direct subscription of 374,532 new ordinary shares at £8.01 each, with net proceeds designated to acce...
Hemogenyx Pharmaceuticals plc has filed its annual Investigational New Drug (IND) report with the FDA for HG-CT-1, a CAR-T cell therapy for relapsed or refractory acute myeloid ...
Hemogenyx Pharmaceuticals plc has successfully completed the technology transfer for its HG-CT-1 CAR-T cell therapy manufacturing to Made Scientific and submitted a comparabilit...
Review valuation context for Hemogenyx Pharmaceuticals Plc.
Review future growth context for Hemogenyx Pharmaceuticals Plc.
Review past performance context for Hemogenyx Pharmaceuticals Plc.
Review financial health context for Hemogenyx Pharmaceuticals Plc.
Review dividend context for Hemogenyx Pharmaceuticals Plc.
Review management context for Hemogenyx Pharmaceuticals Plc.
Review ownership context for Hemogenyx Pharmaceuticals Plc.
Review other information context for Hemogenyx Pharmaceuticals Plc.
Review community context for Hemogenyx Pharmaceuticals Plc.